These benefits, along with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 guidance the notion of targeting ACKR3 as a singular approach to modulate the opioid method, which could open new therapeutic avenues for opioid-similar Problems. Take note: Results may possibly vary https://ariannai405evl1.mybuzzblog.com/profile